The optimal duration of dual antiplatelet therapy (DAPT) for patients implanted with new-
generation drug-eluting stents in East Asians is currently still controversial. The purpose of …

Aims: Current guidelines recommend the use of dual antiplatelet therapy (DAT)(aspirin+
clopidogrel) for patients after acute myocardial infarction (MI). In relation to this, we sought to …

Background Dual antiplatelet therapy (DAPT) is essential in mitigating adverse ischemic
events after myocardial infarction (MI), and current guidelines have recommended the …

Aim. To evaluate an adequacy of dual antiplatelet therapy (DAPT) in patients with acute
coronary syndrome (ACS) with ST segment elevation and bare metal stent implantation after …

In the setting of atherosclerotic coronary artery disease requiring myocardial
revascularization, the goal of dual antiplatelet therapy (DAPT) is to prevent local thrombotic …

Background Adherence to dual antiplatelet therapy (DAPT) is critical after coronary stenting.
Although adherence rates are frequently assessed in clinical trials, adherence rates in the …

We thank Lozano et al for their interest in our study on the eligibility to intensified
antithrombotic regimens (ie, prolonged dual antiplatelet therapy [DAPT] and dual pathway …

Background Treatment with aspirin and a P2Y12 inhibitor is commonly used in patients with
cardiovascular disorders. The overall effect of such treatment on all-cause mortality is …

Much debate has centered on whether or not the standard 12-month duration of dual
antiplatelet therapy (DAPT) is still necessary postpercutaneous coronary intervention, given …

Dual antiplatelet therapy (DAPT), the combination of aspirin (ASA), and a P2Y 12 inhibitor,
protects against stent thrombosis and new atherothrombotic events after a stent implantation …